NCT06721910 Interplay Between Interleukin-6 and Glucagon in the Regulation of Human Amino Acid and Protein Homeostasis Status COMPLETED Phase NA
NCT06654882 Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis Status RECRUITING Phase PHASE3
NCT06624436 Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia Status RECRUITING Phase PHASE4
NCT06624085 A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Status RECRUITING Phase PHASE1
NCT06498089 A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis Status RECRUITING Phase PHASE4
NCT06452537 Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06447701 Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis Status NOT_YET_RECRUITING Phase PHASE3
NCT06381661 Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial Status NOT_YET_RECRUITING Phase PHASE2
NCT06372574 A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors Status WITHDRAWN Phase PHASE1
NCT06367517 Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease) Status RECRUITING Phase N/A
NCT06297096 Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease Status RECRUITING Phase PHASE3
NCT06251076 Plan Development for Giving Teclistamab in the Outpatient Setting Status RECRUITING Phase PHASE4
NCT06238024 Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment Status COMPLETED Phase PHASE2/PHASE3
NCT06084936 A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma Status RECRUITING Phase PHASE3
NCT06043674 Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation Status RECRUITING Phase PHASE2
NCT06016517 Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis Status NOT_YET_RECRUITING Phase N/A
NCT06016179 Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer Status RECRUITING Phase PHASE1
NCT05972135 Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma Status RECRUITING Phase PHASE2